Cargando…

Tocilizumab-effective multicentric Castleman's disease with infiltration of eosinophil and IgG(4)-positive plasma cells: A case report

A 67-year-old woman with fever and cough was diagnosed with eosinophilic pneumonia because of eosinophilia and increased eosinophil levels in the bronchoalveolar lavage fluid and transbronchial biopsy lung specimens. However, prednisolone therapy at a previous hospital was ineffective. Histological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katsumata, Yusuke, Ikari, Jun, Tanaka, Nozomi, Abe, Mitsuhiro, Tsushima, Kenji, Yonemori, Yoko, Tatsumi, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038330/ https://www.ncbi.nlm.nih.gov/pubmed/29998054 http://dx.doi.org/10.1016/j.rmcr.2018.06.001

Ejemplares similares

Multicentric Castleman disease with infiltration of eosinophils to the lung
por: Nakai, Shogo, et al.
Publicado: (2021)

Distinct features distinguishing IgG4-related disease from multicentric Castleman’s disease
por: Sasaki, Takanori, et al.
Publicado: (2017)

Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab
por: Aita, Tetsuro, et al.
Publicado: (2020)

Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease
por: Otani, Kyoko, et al.
Publicado: (2018)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011)

Diffuse cryptococcal pneumonia in multicentric Castleman’s disease with elevated serum IgG(4)
por: Takiguchi, Junji, et al.
Publicado: (2023)

Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report
por: Sugawara, Eri, et al.
Publicado: (2022)

An Analysis of the Clinical Benefit of 37 Bronchoalveolar Lavage Procedures in Patients with Hematologic Disease and Pulmonary Complications
por: Katsumata, Yusuke, et al.
Publicado: (2018)

Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions
por: Mochizuki, Hiroki, et al.
Publicado: (2017)

Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman Disease
por: Togitani, Kazuto, et al.
Publicado: (2022)

Investigation of IgG4‐positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4‐related disease
por: Nishikori, Asami, et al.
Publicado: (2021)

Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report
por: Cai, Sisi, et al.
Publicado: (2019)

Idiopathic Multicentric Castleman Disease with Strikingly Elevated IgG4 Concentration in the Serum and Abundant IgG4-Positive Cells in the Tissue: A Case Report
por: Cheng, Chia-Chun, et al.
Publicado: (2022)

Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
por: Han, Ping-Yang, et al.
Publicado: (2020)

Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease
por: Arakawa, Akira, et al.
Publicado: (2021)

Different Types of Skin Lesions in Multicentric Castleman Disease
por: Nakamura, Yoshihiro, et al.
Publicado: (2022)

Role of IgG, IgA, and IgE antibodies in nasal polyp tissue: their relationships with eosinophilic infiltration and degranulation.
por: Suh, Kyung-Sik, et al.
Publicado: (2002)

Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study
por: Abe, Mitsuhiro, et al.
Publicado: (2018)

Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab
por: Tabata, Sakiko, et al.
Publicado: (2019)

Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter]
por: Abe, Mitsuhiro, et al.
Publicado: (2019)

DLI Induced by Herbal Medicine: What Are the Characteristics of DLI due to Herbal Medicines?
por: Abe, Mitsuhiro, et al.
Publicado: (2017)

Increased serum IgG4 levels and intimal IgG4-positive cell infiltration in rapidly growing aortic aneurysm
por: Fujita, Shuichi, et al.
Publicado: (2013)

Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature
por: Saiki, Ryosuke, et al.
Publicado: (2021)

Eosinophilic granulomatous polyangiitis with IgG4 hypergammaglobulinaemia and salivary gland swelling
por: Takahashi, Koichiro, et al.
Publicado: (2020)

Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease
por: Nishimura, Midori Filiz, et al.
Publicado: (2020)

PB1953: TWELVE CASES OF MULTICENTRIC CASTLEMAN DISEASE WITH ELEVATED SERUM IGG4 LEVELS AND INFILTRATING IGG4 POSITIVE PLASMA CELLS PATHOLOGICALLY FROM A SINGLE CENTER.
por: Dai, Shishuo, et al.
Publicado: (2023)

Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
por: Vargas, Ana Beatriz, et al.
Publicado: (2012)

Refractory Uveitis in Patient with Castleman Disease Successfully Treated with Tocilizumab
por: Oshitari, Toshiyuki, et al.
Publicado: (2012)

Relationship between chronic sclerosing dacryoadenitis with high level of IgG4 and Castleman disease
por: Oshitari, Toshiyuki, et al.
Publicado: (2011)

Inflammatory pseudotumor of Castleman disease and IgG4-related disease masquerading as kidney malignancy
por: Liu, Bolong, et al.
Publicado: (2021)

A Rare Case of Orbital Castleman Disease with Overlapping IgG4-Related Disease
por: Liu, Li-Ching, et al.
Publicado: (2023)

Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: a report of three cases
por: Komaba, Hirotaka, et al.
Publicado: (2008)

HIV-associated multicentric Castleman's disease
por: Naime, Fauzia de Fátima, et al.
Publicado: (2012)

Multicentric Castleman disease and the evolution of the concept
por: Zhou, Ting, et al.
Publicado: (2021)

Pre- and post-therapy (18)F-FDG PET/CT of a patient affected by non-HIV multicentric IgG4-related Castleman disease
por: Savelli, Giordano, et al.
Publicado: (2015)

Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease
por: Kubo, Satoshi, et al.
Publicado: (2022)

Polymyositis with elevated serum IgG4 levels and abundant IgG4(+) plasma cell infiltration: A case report and literature review
por: Anan, Ryusuke, et al.
Publicado: (2017)

Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan
por: Masaki, Yasufumi, et al.
Publicado: (2019)

A Case of Multicentric Castleman's Disease Having Lung Lesion Successfully Treated with Humanized Anti-interleukin-6 Receptor Antibody, Tocilizumab
por: Higuchi, Tomoaki, et al.
Publicado: (2010)

Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases
por: Nagao, Azusa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2apr8velbdj8lf9ua7ejm0j6qf